Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Intra-Uterine Contraceptive Devices Market by Type (Copper IUCD, Hormonal IUCD), By Application (Hospitals, Gynaecology clinics, Community healthcare) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028-report

Global Intra-Uterine Contraceptive Devices Market by Type (Copper IUCD, Hormonal IUCD), By Application (Hospitals, Gynaecology clinics, Community healthcare) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Report ID: 197173 3300 Medical Devices & Consumables 377 238 Pages
                                          

Industry Growth Insights published a new data on “Intra-Uterine Contraceptive Devices Market”. The research report is titled “Intra-Uterine Contraceptive Devices Market research by Types (Copper IUCD, Hormonal IUCD), By Applications (Hospitals, Gynaecology clinics, Community healthcare), By Players/Companies Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed”. As per the latest research Intra-Uterine Contraceptive Devices market is expected to expand at a CAGR of xx% in the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Intra-Uterine Contraceptive Devices Market Research Report

By Type

Copper IUCD, Hormonal IUCD

By Application

Hospitals, Gynaecology clinics, Community healthcare

By Companies

Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

2028

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Intra-Uterine Contraceptive Devices Industry Outlook

Global Intra-Uterine Contraceptive Devices Market Report Segments:

The global Intra-Uterine Contraceptive Devices market is segmented on the basis of:

Types

Copper IUCD, Hormonal IUCD

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Gynaecology clinics, Community healthcare

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bayer AG
  2. Teva Pharmaceuticals Industries
  3. Mona Lisa N.V.
  4. DKT International
  5. Egemen International
  6. Melbea AG
  7. Ocon Medical Ltd.
  8. Pregna International Limited
  9. Medical Engineering Corporation SA
  10. SMB Corporation and Meril Life Sciences Pvt. Ltd.
  11. Medu Scientific Ltd, China RH Contraceptives Co., Ltd
  12. Sanghai Jolly Medical Education Co., Ltd
  13. Bernstein Leibhard LLP
  14. Zheijang Daji Medical Instruments, Ltd.
  15. Nimble International
  16. AME Line, Technico
  17. Cepeo
  18. Contraceptivos
  19. Injeflex Ind And Com Ltda
  20. Bersil
  21. Amed

Global Intra-Uterine Contraceptive Devices Market Overview

Highlights of The Intra-Uterine Contraceptive Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

    1. Copper IUCD
    2. Hormonal IUCD
  1. By Application:

    1. Hospitals
    2. Gynaecology clinics
    3. Community healthcare
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intra-Uterine Contraceptive Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Intra-Uterine Contraceptive Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Intra-Uterine Contraceptive Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Intra-Uterine Contraceptive Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Intra-Uterine Contraceptive Devices Market - Supply Chain
   4.5. Global Intra-Uterine Contraceptive Devices Market Forecast
      4.5.1. Intra-Uterine Contraceptive Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Intra-Uterine Contraceptive Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Intra-Uterine Contraceptive Devices Market Absolute $ Opportunity

5. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      5.3.1. Copper IUCD
      5.3.2. Hormonal IUCD
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Gynaecology clinics
      6.3.3. Community healthcare
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026

9. North America Intra-Uterine Contraceptive Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Gynaecology clinics
      9.4.3. Community healthcare
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      9.7.1. Copper IUCD
      9.7.2. Hormonal IUCD
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026

10. Latin America Intra-Uterine Contraceptive Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Gynaecology clinics
      10.4.3. Community healthcare
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      10.7.1. Copper IUCD
      10.7.2. Hormonal IUCD
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026

11. Europe Intra-Uterine Contraceptive Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Gynaecology clinics
      11.4.3. Community healthcare
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      11.7.1. Copper IUCD
      11.7.2. Hormonal IUCD
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.0. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Intra-Uterine Contraceptive Devices Demand Share, 2019-2026

12. Asia Pacific Intra-Uterine Contraceptive Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Gynaecology clinics
      12.4.3. Community healthcare
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      12.7.1. Copper IUCD
      12.7.2. Hormonal IUCD
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Intra-Uterine Contraceptive Devices Demand Share, 2019-2026

13. Middle East & Africa Intra-Uterine Contraceptive Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Gynaecology clinics
      13.4.3. Community healthcare
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
      13.7.1. Copper IUCD
      13.7.2. Hormonal IUCD
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Intra-Uterine Contraceptive Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Intra-Uterine Contraceptive Devices Market: Market Share Analysis
   14.2. Intra-Uterine Contraceptive Devices Distributors and Customers
   14.3. Intra-Uterine Contraceptive Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Bayer AG
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Teva Pharmaceuticals Industries
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Mona Lisa N.V.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. DKT International
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Egemen International
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Melbea AG
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Ocon Medical Ltd.
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Pregna International Limited
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Medical Engineering Corporation SA
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. SMB Corporation and Meril Life Sciences Pvt. Ltd.
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Medu Scientific Ltd, China RH Contraceptives Co., Ltd
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Sanghai Jolly Medical Education Co., Ltd
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Bernstein Leibhard LLP
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Zheijang Daji Medical Instruments, Ltd.
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Nimble International
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. AME Line, Technico
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Cepeo
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Contraceptivos
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Injeflex Ind And Com Ltda
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Bersil
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us